Analysts' Outlook on Redcare Pharmacy NV (ETR:RDC): Is Optimism in the Air?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 24 2025
0mins
Should l Buy ?
Source: Yahoo Finance
Company Overview: Redcare Pharmacy NV operates online pharmacies across several European countries and is nearing breakeven after significant financial losses in recent years.
Profitability Expectations: Analysts predict that Redcare Pharmacy will achieve profitability by 2026, requiring an average annual growth rate of 54% to meet this target.
Debt Concerns: The company currently has a high debt level at 73% of equity, which raises investment risks given its ongoing losses.
Further Analysis: For deeper insights into Redcare Pharmacy's valuation, management team, and comparison with other stocks, additional resources are available on Simply Wall St.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
